Who owns SUPERNUS PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SUPN from SEC Form 13F filings across 294 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 294 institutions disclosed 57.0M shares of SUPERNUS PHARMACEUTICALS, INC. worth $2.46B — about 98% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
294
13F holders
$2.46B
value, 2026 filers
98%
of shares outstanding (57.0M sh)
33
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SUPN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.0M | $428.6M | 0.0% | 17.1% | +6.5% |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.3M | $141.4M | 0.0% | 5.6% | -0.6% |
| 3 | STATE STREET CORP | 2.6M | $110.6M | 0.0% | 4.4% | +4.4% |
| 4 | ARMISTICE CAPITAL, LLC | 2.5M | $109.7M | 1.3% | 4.4% | -3.7% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | $108.6M | 0.0% | 4.3% | +0.2% |
| 6 | MILLENNIUM MANAGEMENT LLC | 2.0M | $84.9M | 0.0% | 3.4% | -48.8% |
| 7 | DIMENSIONAL FUND ADVISORS LP | 1.8M | $79.3M | 0.0% | 3.2% | -11.3% |
| 8 | Rubric Capital Management LPNEW | 1.7M | $74.9M | 0.7% | 3% | new |
| 9 | Stephens Investment Management Group LLC | 1.6M | $70.5M | 0.8% | 2.8% | +10.2% |
| 10 | TWO SIGMA INVESTMENTS, LP | 1.6M | $70.0M | 0.0% | 2.8% | +37.3% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 1.5M | $65.9M | 0.0% | 2.6% | -2.5% |
| 12 | LOOMIS SAYLES & CO L P | 1.4M | $61.8M | 0.1% | 2.5% | -2.7% |
| 13 | GW&K Investment Management, LLC | 1.4M | $59.1M | 0.5% | 2.4% | +32.5% |
| 14 | MORGAN STANLEY | 1.2M | $50.4M | 0.0% | 2% | +33.5% |
| 15 | RENAISSANCE TECHNOLOGIES LLC | 1.1M | $48.7M | 0.1% | 1.9% | -23.4% |
| 16 | GOLDMAN SACHS GROUP INC | 1.1M | $48.0M | 0.0% | 1.9% | +36.1% |
| 17 | Qube Research & Technologies Ltd | 881,138 | $37.9M | 0.0% | 1.5% | -4.4% |
| 18 | CITADEL ADVISORS LLC | 828,901 | $35.7M | 0.0% | 1.4% | -39.7% |
| 19 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 804,930 | $34.6M | 0.7% | 1.4% | +69.8% |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 723,864 | $31.2M | 0.0% | 1.2% | +2.9% |
| 21 | NORTHERN TRUST CORP | 707,046 | $30.4M | 0.0% | 1.2% | -3.6% |
| 22 | ASHFORD CAPITAL MANAGEMENT INC | 616,986 | $26.6M | 2.9% | 1.1% | +0.5% |
| 23 | Woodline Partners LP | 609,789 | $26.2M | 0.1% | 1% | -13.9% |
| 24 | Jones Hill Capital LPNEW | 601,685 | $25.9M | 4.4% | 1% | new |
| 25 | BANK OF AMERICA CORP /DE/ | 597,227 | $25.7M | 0.0% | 1% | -3.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.